Zivo Bioscience, Inc.
ZIVO
$13.25
-$3.96-23.01%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.32M | -13.38M | -13.69M | -13.25M | -7.08M |
| Total Depreciation and Amortization | 98.30K | 98.30K | 91.00K | 91.00K | 91.00K |
| Total Amortization of Deferred Charges | -- | -- | 4.90K | 224.70K | 439.60K |
| Total Other Non-Cash Items | 12.46M | 9.47M | 8.82M | 7.80M | 164.10K |
| Change in Net Operating Assets | -285.90K | -500.50K | 655.80K | 126.40K | 1.02M |
| Cash from Operations | -4.04M | -4.31M | -4.12M | -5.01M | -5.37M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 488.20K | 517.60K | 667.60K | 667.60K | 1.67M |
| Total Debt Repaid | -563.90K | -538.20K | -1.69M | -1.72M | -1.75M |
| Issuance of Common Stock | 4.50M | 5.60M | 3.82M | 6.04M | 5.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.42M | 5.58M | 2.80M | 4.99M | 5.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 378.40K | 1.27M | -1.33M | -18.60K | -69.90K |